Company: WW
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001193125-25-087213
Chunk: 2

Company: WW INTERNATIONAL, INC.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 2
---
 Inc. is a Virginia corporation with its principal executive offices in New York, New York. In this Proxy Statement, unless the context indicates otherwise, “we”, “us”, “our”, “WW,” and the “Company” refer to WW International, Inc. and all of its operations consolidated for purposes of its financial statements. Our “Clinical” business refers to providing subscriptions to our clinical product offerings provided by WeightWatchers Clinic (formerly referred to as Sequence) combined with our digital subscription product offerings and unlimited access to our workshops. “Subscription Revenues” consist of the aggregate fees associated with subscriptions for our offerings. “End of Period Subscribers” is the aggregate number of subscribers for our offerings at a given period end. Our fiscal year ends on the Saturday closest to December 31st and consists of either 52-or 53-weekperiods. In this Proxy Statement:

iii

<div align='center'>**INFORMATION ABOUT THE 2025 ANNUAL MEETING OF SHAREHOLDERS AND VOTING**</div>

**The Board of Directors of WW International, Inc. is soliciting proxies for the Company’s 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”) to be held virtually via live audio webcast at www.cesonlineservices.com/ww25_vm on Friday, June 6, 2025, at 10:00 a.m. Eastern Time, and at any and all adjournments or postponements thereof. This Proxy Statement and the accompanying proxy card contain information about the items shareholders will vote on at the 2025 Annual Meeting, and at any and all adjournments or postponements thereof. It is anticipated that this Proxy Statement and the accompanying proxy card will first be mailed to shareholders on or about April 21, 2025.

Who is entitled to vote?

As of the close of business on April 2, 2025 (such date and time, the “Record Date”), there were 80,259,742 shares of common stock, no par value per share, of the Company (the “Common Stock”) outstanding. If you are a shareholder of record or a beneficial owner of Common Stock on the Record Date, you are entitled to receive notice of and to vote at the 2025 Annual Meeting and at any and all adjournments or postponements of the 2025 Annual Meeting. You are entitled to one vote for each share of Common Stock you hold as a shareholder of record or as beneficial owner for each matter presented for vote